263 related articles for article (PubMed ID: 31970266)
1. Organoid-based regenerative medicine for inflammatory bowel disease.
Okamoto R; Shimizu H; Suzuki K; Kawamoto A; Takahashi J; Kawai M; Nagata S; Hiraguri Y; Takeoka S; Sugihara HY; Yui S; Watanabe M
Regen Ther; 2020 Mar; 13():1-6. PubMed ID: 31970266
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
3. Organoid Medicine for Inflammatory Bowel Disease.
Wakisaka Y; Sugimoto S; Sato T
Stem Cells; 2022 Mar; 40(2):123-132. PubMed ID: 35258629
[TBL] [Abstract][Full Text] [Related]
4. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.
Okamoto R; Watanabe M
J Gastroenterol; 2016 Jan; 51(1):11-21. PubMed ID: 26138071
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-based therapy for inflammatory bowel disease.
Shimizu H; Suzuki K; Watanabe M; Okamoto R
Intest Res; 2019 Jul; 17(3):311-316. PubMed ID: 31352774
[TBL] [Abstract][Full Text] [Related]
6. Disease Severity Impairs Generation of Intestinal Organoid Cultures From Inflammatory Bowel Disease Patients.
Ding W; Marx OM; Mankarious MM; Koltun WA; Yochum GS
J Surg Res; 2024 Jan; 293():187-195. PubMed ID: 37776721
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
[TBL] [Abstract][Full Text] [Related]
8. IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model.
Zwarycz B; Gracz AD; Rivera KR; Williamson IA; Samsa LA; Starmer J; Daniele MA; Salter-Cid L; Zhao Q; Magness ST
Cell Mol Gastroenterol Hepatol; 2019; 7(1):1-17. PubMed ID: 30364840
[TBL] [Abstract][Full Text] [Related]
9. Single cell analysis of Crohn's disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties.
Suzuki K; Murano T; Shimizu H; Ito G; Nakata T; Fujii S; Ishibashi F; Kawamoto A; Anzai S; Kuno R; Kuwabara K; Takahashi J; Hama M; Nagata S; Hiraguri Y; Takenaka K; Yui S; Tsuchiya K; Nakamura T; Ohtsuka K; Watanabe M; Okamoto R
J Gastroenterol; 2018 Sep; 53(9):1035-1047. PubMed ID: 29374777
[TBL] [Abstract][Full Text] [Related]
10. Development and Application of Regenerative Medicine in Inflammatory Bowel Disease.
Okamoto R; Mizutani T; Shimizu H
Digestion; 2023; 104(1):24-29. PubMed ID: 36353779
[TBL] [Abstract][Full Text] [Related]
11. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.
Yoo JH; Donowitz M
World J Gastroenterol; 2019 Aug; 25(30):4125-4147. PubMed ID: 31435168
[TBL] [Abstract][Full Text] [Related]
12. Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration.
Sorrentino G; Perino A; Yildiz E; El Alam G; Bou Sleiman M; Gioiello A; Pellicciari R; Schoonjans K
Gastroenterology; 2020 Sep; 159(3):956-968.e8. PubMed ID: 32485177
[TBL] [Abstract][Full Text] [Related]
13. HucMSC-Exo Promote Mucosal Healing in Experimental Colitis by Accelerating Intestinal Stem Cells and Epithelium Regeneration via Wnt Signaling Pathway.
Liang X; Li C; Song J; Liu A; Wang C; Wang W; Kang Y; Sun D; Qian J; Zhang X
Int J Nanomedicine; 2023; 18():2799-2818. PubMed ID: 37256205
[TBL] [Abstract][Full Text] [Related]
14. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models.
Yang H; Feng R; Fu Q; Xu S; Hao X; Qiu Y; Feng T; Zeng Z; Chen M; Zhang S
Cell Death Dis; 2019 Sep; 10(10):718. PubMed ID: 31558705
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Adak S; Mukherjee S; Sen D
Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
[TBL] [Abstract][Full Text] [Related]
16. Investigating cell therapy for inflammatory bowel disease.
Okamoto R; Watanabe M
Expert Opin Biol Ther; 2016 Aug; 16(8):1015-23. PubMed ID: 27113391
[TBL] [Abstract][Full Text] [Related]
17. Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model mice.
Nakanishi A; Toyama S; Onozato D; Watanabe C; Hashita T; Iwao T; Matsunaga T
Regen Ther; 2022 Dec; 21():351-361. PubMed ID: 36161099
[TBL] [Abstract][Full Text] [Related]
18. Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges.
Tian CM; Zhang Y; Yang MF; Xu HM; Zhu MZ; Yao J; Wang LS; Liang YJ; Li DF
J Inflamm Res; 2023; 16():2089-2119. PubMed ID: 37215379
[TBL] [Abstract][Full Text] [Related]
19. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
[TBL] [Abstract][Full Text] [Related]
20. The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy.
Binienda A; Ziolkowska S; Hauge IH; Salaga M
Curr Drug Targets; 2020; 21(14):1405-1416. PubMed ID: 32364073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
